Member Info for technick

Thanks BigC, Is their target still 0.80p or so?

@BBY, 90.5p, no

I personally think that given the time it's taken that some tweet or social media from the Company to re-state where approvals are pending and something along the lines of 'the Company sees no reason why these will not be received in due course' would help shareholder sentiment and demonstrate that the Company doesn't see anything untoward that fuels speculation... it would help the share price...

4th bullet point interesting for us

https://www.reportlinker.com/p05948435/Post-pandemic-Global-Healthcare-Market-Outlook.html?utm_source=PRN

Second bullet point interesting for us here

https://www.reportlinker.com/p05948435/Post-pandemic-Global-Healthcare-Market-Outlook.html?utm_source=PRN

@big I agree, watch this space. Exciting days and weeks ahead.

Unless you reinvest in other shares and defer the gain until you come to sell those

Danaher own Beckman and the manufacturer Cytiva. They’ll make it work somehow.

Safy that’s interesting and could indicate where GDR are focused in terms of US customer. The fact it’s all then in the Danaher family makes a lot of sense too. Sensational if it pans out that way.

... looks like testing is going to be here a while if infection only buys you 3 months immunity

https://www.axios.com/cdc-covid-19-three-months-immunity-468558d4-3218-424a-84cc-a6c86119ef69.html

Hi BB, when the share-rice was at £3 the market cap was £100m with 35m shares, we are now at 52m shares which would mean a £2 share price if my estimations are correct. So we can easily see a £2 share price just standing still but as you say the Company is in a far better position now than it was then... all down to sales volumes now

There's a real chance of closing above £1 today. News expected shortly and the commercial value of the Beckman collaboration is obvious. Things moving nicely and a series of RNSs over the coming weeks should propel the market cap back to the £100m-£200m range.

I suspect Source use Beckman robotics to achieve their 200k tests per day...

@safy

Thanks Safe, in which case some investors are buying hefty chunks, not your usual day trader transactions.

I'm guessing they are split over a number of transactions but only get reported as one, the initial request.

No due diligence

I agree, how do you give such a large contract to a company that has never delivered a diagnostic product to market? It defies all logic. They obviously sold the concept well and I think Cummings as all about the nudge!

these large delayed trades, whilst obvious they are what is suppressing the share price, do they represent a single transaction, ie £20k trade has been acquired as £20k by someone or can it have been split into smaller trades. At a £20k trade its large and someone who bought as a PI has bought a large chunk, but if it was spit into 20x £1k that's a different matter. Just interested.

something definitely happening here, rising quickly, possibly US shareholder interest on the Beckman announcements?